细胞移植-话题@MedSci

#细胞移植#

279篇内容 | 4621人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1658899, encodeId=1fa516588999f, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制, objectType=article, longId=167613, objectId=b87a16e61344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b87a16e61344, replyNumber=0, likeNumber=75, createdTime=2019-11-29, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b87a16e61344, moduleTitle=英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b87a16e61344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658879, encodeId=d1e916588e937, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Blood：T细胞耗竭导致干细胞移植后骨髓瘤细胞免疫逃逸, objectType=article, longId=147812, objectId=46ff14e81289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46ff14e81289, replyNumber=0, likeNumber=72, createdTime=2018-11-04, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46ff14e81289, moduleTitle=Blood：T细胞耗竭导致干细胞移植后骨髓瘤细胞免疫逃逸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46ff14e81289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658898, encodeId=bb3116588983c, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, objectType=article, longId=166721, objectId=b315166e2142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b315166e2142, replyNumber=0, likeNumber=85, createdTime=2019-09-11, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b315166e2142, moduleTitle=Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b315166e2142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658894, encodeId=449e16588943b, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=2019 EBMT共识建议：单倍体造血干细胞移植供者的选择, objectType=article, longId=162846, objectId=a92e16284603, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a92e16284603, replyNumber=0, likeNumber=16, createdTime=2019-08-03, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92e16284603, moduleTitle=2019 EBMT共识建议：单倍体造血干细胞移植供者的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a92e16284603)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658889, encodeId=2eb61658889d0, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险, objectType=article, longId=157423, objectId=953415e4233d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=953415e4233d, replyNumber=0, likeNumber=67, createdTime=2019-01-15, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=953415e4233d, moduleTitle=Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=953415e4233d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658891, encodeId=9f3816588918d, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Scientific Reports：肝巨噬细胞耗竭可以改善间充质干细胞移植对小鼠肝损伤模型的影响, objectType=article, longId=158529, objectId=f4801585292f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4801585292f, replyNumber=0, likeNumber=60, createdTime=2019-08-21, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4801585292f, moduleTitle=Scientific Reports：肝巨噬细胞耗竭可以改善间充质干细胞移植对小鼠肝损伤模型的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4801585292f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658870, encodeId=7be216588e09e, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=干细胞移植会成为肥胖症的治疗良药吗？, objectType=article, longId=142420, objectId=979d14242068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=979d14242068, replyNumber=0, likeNumber=64, createdTime=2019-01-05, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=979d14242068, moduleTitle=干细胞移植会成为肥胖症的治疗良药吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=979d14242068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658890, encodeId=8a0216588905e, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法, objectType=article, longId=158465, objectId=a47115846533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a47115846533, replyNumber=0, likeNumber=57, createdTime=2019-11-26, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a47115846533, moduleTitle=JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a47115846533)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658884, encodeId=0c47165888471, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=JAMA ONCOL：造血干细胞移植后继发实体瘤患者预后评估, objectType=article, longId=154724, objectId=8010154e24c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8010154e24c4, replyNumber=0, likeNumber=109, createdTime=2018-12-17, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8010154e24c4, moduleTitle=JAMA ONCOL：造血干细胞移植后继发实体瘤患者预后评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8010154e24c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658888, encodeId=927616588880d, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=吴德沛教授：自体干细胞移植在多发性骨髓瘤治疗中的地位稳固如初, objectType=article, longId=155980, objectId=901615598085, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=901615598085, replyNumber=0, likeNumber=82, createdTime=2019-01-11, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=901615598085, moduleTitle=吴德沛教授：自体干细胞移植在多发性骨髓瘤治疗中的地位稳固如初, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=901615598085)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658880, encodeId=a403165888057, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Blood：重度联合型免疫缺陷患者进行造血细胞移植后6个月，CD4+细胞计数即可预测存活率和免疫重建, objectType=article, longId=148023, objectId=ca86148023ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca86148023ac, replyNumber=0, likeNumber=61, createdTime=2018-09-21, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca86148023ac, moduleTitle=Blood：重度联合型免疫缺陷患者进行造血细胞移植后6个月，CD4+细胞计数即可预测存活率和免疫重建, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca86148023ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658883, encodeId=c5611658883b1, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, objectType=article, longId=153017, objectId=649b15301eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649b15301eb0, replyNumber=0, likeNumber=68, createdTime=2019-05-05, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649b15301eb0, moduleTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649b15301eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658857, encodeId=1031165885e19, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Nat Med：首次证实人神经干细胞移植可改善脊髓损伤猴子的抓力, objectType=article, longId=134173, objectId=70851341e313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70851341e313, replyNumber=0, likeNumber=52, createdTime=2018-08-06, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70851341e313, moduleTitle=Nat Med：首次证实人神经干细胞移植可改善脊髓损伤猴子的抓力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70851341e313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658874, encodeId=b21016588e4a9, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=不符合自体干细胞移植的多发性骨髓瘤患者的福音, objectType=article, longId=145410, objectId=552c145410cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=552c145410cb, replyNumber=0, likeNumber=69, createdTime=2018-10-14, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=552c145410cb, moduleTitle=不符合自体干细胞移植的多发性骨髓瘤患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=552c145410cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658886, encodeId=9450165888685, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Lancet：自体干细胞移植后Ixazomib的维持治疗, objectType=article, longId=155613, objectId=947f155613fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947f155613fd, replyNumber=0, likeNumber=0, createdTime=2019-04-18, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947f155613fd, moduleTitle=Lancet：自体干细胞移植后Ixazomib的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947f155613fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658877, encodeId=09e016588e767, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=三期临床使用干细胞移植在克罗恩病患者体中培育新的免疫系统, objectType=article, longId=146240, objectId=657c146240c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=657c146240c3, replyNumber=0, likeNumber=43, createdTime=2018-09-18, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=657c146240c3, moduleTitle=三期临床使用干细胞移植在克罗恩病患者体中培育新的免疫系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=657c146240c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658869, encodeId=58d41658869f0, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证, objectType=article, longId=142310, objectId=66f314231017, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66f314231017, replyNumber=0, likeNumber=50, createdTime=2019-04-18, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66f314231017, moduleTitle=2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66f314231017)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658881, encodeId=17aa165888108, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）, objectType=article, longId=149148, objectId=44dc1491489b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44dc1491489b, replyNumber=0, likeNumber=17, createdTime=2019-01-29, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44dc1491489b, moduleTitle=2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44dc1491489b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658871, encodeId=f37016588e165, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=Blood：可降低HLH和原发性免疫缺陷患者进行造血细胞移植前的骨髓清扫强度！, objectType=article, longId=144337, objectId=85fc14433e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85fc14433e97, replyNumber=0, likeNumber=53, createdTime=2019-02-11, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85fc14433e97, moduleTitle=Blood：可降低HLH和原发性免疫缺陷患者进行造血细胞移植前的骨髓清扫强度！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85fc14433e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658864, encodeId=2cd8165886490, content=<a href='/topic/show?id=c40ce798412' target=_blank style='color:#2F92EE;'>#细胞移植#</a>, objectTitle=吴祖泽：曾以胎肝造血干细胞移植救治放射病, objectType=article, longId=137427, objectId=c50c13e42720, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c50c13e42720, replyNumber=0, likeNumber=90, createdTime=2018-06-22, rootId=0, userName=limedical1982, userId=ad4724938298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c50c13e42720, moduleTitle=吴祖泽：曾以胎肝造血干细胞移植救治放射病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c50c13e42720)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞移植

2020-05-29

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

英国NICE推荐将MSD的Prevymis，用于造血干细胞移植后巨细胞病毒的控制

2019-11-29

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Blood：T细胞耗竭导致干细胞移植后骨髓瘤细胞免疫逃逸

2018-11-04

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Be The Match BioTherapies和Kiadis Pharma宣布战略合作以加速造血干细胞移植疗法

2019-09-11

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

2019 EBMT共识建议：单倍体造血干细胞移植供者的选择

2019-08-03

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险

2019-01-15

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Scientific Reports：肝巨噬细胞耗竭可以改善间充质干细胞移植对小鼠肝损伤模型的影响

2019-08-21

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

干细胞移植会成为肥胖症的治疗良药吗？

2019-01-05

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法

2019-11-26

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

JAMA ONCOL：造血干细胞移植后继发实体瘤患者预后评估

2018-12-17

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

吴德沛教授：自体干细胞移植在多发性骨髓瘤治疗中的地位稳固如初

2019-01-11

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Blood：重度联合型免疫缺陷患者进行造血细胞移植后6个月，CD4+细胞计数即可预测存活率和免疫重建

2018-09-21

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

2019-05-05

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Nat Med：首次证实人神经干细胞移植可改善脊髓损伤猴子的抓力

2018-08-06

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

不符合自体干细胞移植的多发性骨髓瘤患者的福音

2018-10-14

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Lancet：自体干细胞移植后Ixazomib的维持治疗

2019-04-18

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

三期临床使用干细胞移植在克罗恩病患者体中培育新的免疫系统

2018-09-18

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证

2019-04-18

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）

2019-01-29

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

Blood：可降低HLH和原发性免疫缺陷患者进行造血细胞移植前的骨髓清扫强度！

2019-02-11

limedical1982 (审核中...)

前往app查看评论内容

#细胞移植#

吴祖泽：曾以胎肝造血干细胞移植救治放射病

2018-06-22

科室
- - 订阅+
  - 更多科室
工具
服务